I don't care what anyone else says about this, I believe this is huge, and if they get an opportunity to get the product approved in China, Japan and South Korea the sky is the limit.
Also, this creates a bit of competition with the FDA, as they would not want this approved in China before approval in America.
Forget about the sp, it is irrelevant, we know what we have, Imugene know what they have, it is only a matter of time and successful trial data between here and the moon.
DYOR opinion only
Ann: Oncolytic Virotherapy CF33 Patent Granted in China, page-92
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $163.8K | 3.371M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 71 | 7835807 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2457786 | 22 |
View Market Depth
| Last trade - 13.33pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |